3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
13
Lymphoma
13
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Hodgkin Disease
5
Leukemia
4
Neoplasms
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Leukemia, Biphenotypic, Acute
3
Burkitt Lymphoma
3
Breast Neoplasms
3
Recurrence
2
Ovarian Neoplasms
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Immunoblastic Lymphadenopathy
2
Hemangioma
2
Enteropathy-Associated T-Cell Lymphoma
2
Stomatitis
1
Stomach Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Peripheral Nervous System Diseases
1
Oral Ulcer
1
Neurotoxicity Syndromes
1
Neoadjuvant Therapy
1
Multiple Myeloma
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer Patients
1
Interventions
Cyclophosphamide
10
ofatumumab
8
fludarabine
6
Rituximab
5
fludarabine phosphate
4
Bendamustine Hydrochloride
4
venetoclax
3
obinutuzumab
3
ibrutinib
3
acalabrutinib
3
Melphalan
3
pirtobrutinib
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Lenalidomide
2
Immunotherapy, Adoptive
2
Busulfan
2
Bortezomib
2
Alemtuzumab
2
zanubrutinib
1
thymoglobulin
1
tenofovir alafenamide
1
pomalidomide
1
pivalyloxymethyl butyrate
1
pegaspargase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Leukemia, B-Cell
×
Prednisolone
×
Clear all
NCT03899337
2023-01-09
STELLAR
University of Birmingham
Phase 2
Recruiting
105 enrolled